Investor Relations

A Message From Our CEO

Globally there is a paradigm shift in the way people think about their health and wellbeing, not just conceptually, but in the products consumers choose to purchase. SpectrumX will have a part to play in nearly every aspect of this shift in society; from saving patients’ lives in hospitals, to providing consumers with innovative, safe and effective solutions for sanitisation and personal care. With the combination of our world renowned team, innovative developments and intellectual property, it is SpectrumX’s mission to be a globally leading HOCL health company, offering a better way to protect and improve people’s lives around the world.

Damien Hancox, CEO

Damien Hancox, CEO

Scientific Innovation - Hypochlorous Acid (HOCL)

We are a biotech company who specialise in the development and consumer implementation of Hypochlorous Acid (HOCL).

Historically overlooked by Big Pharma, HOCL has almost limitless potential applications. It is one of the most effective biocides known to man. It eradicates all bacteria, mycobacteria, spores, fungi, viruses – including COVID-19 – within 15 seconds. It is 300x stronger than bleach but 100% safe for human use. HOCL is produced by white blood cells in our bodies to fight infections and is one of the main reasons humans have evolved over millions of years.

We are the first biotech company to stabilise, patent and integrate new medical technology to harness the multitude of benefits HOCL has for mass consumer use.

The Partnership - SpectrumX & Spectrum Antimicrobials

Founded in 2016 by Hoji Alimi, Spectrum Antimicrobials Inc are an infection control solutions company. Spectrum Antimicrobials and SpectrumX formed a mutually beneficial partnership in July 2020. SpectrumX holds licenses, for commercialisation of, various applications of the unique HOCL formulations developed by Spectrum Antimicrobials.

HOCl has never previously been patent protectable. This all changed with the creation of Spectrum Antimicrobial’s development of their PKU platform – Spectricept.

It is the only company in the world to have registered a patent on a finished HOCL product. They additionally have created a formulation that not only has excellent shelf life but additionally maintains efficacy in the presence of serum (blood, salvia, dirt etc). This is key because the product works in “real world” conditions where all other HOCL products and manufacturers have failed.

Key Team Members

Click on each team members photo to read more about their role and experience.

CEO
Damien Hancox

Director
Ben Hibbert

Strategic Investor
Aziz McMahon

Spectrum Antimicrobials
Hoji Alimi

Medical Advisor
Professor Dennis Kinane

Commercial Advisor
Lord Shrewsbury

Medical Advisor
Gordon Buchanan

Commercial Advisor
Derek Brown

Commercial Advisor
Dr Alexander Nill

Marketing Director
Jennifer Von Strohe

Communications Director
Susy Castro

Technical & Engineering Advisor
Dr Colin Petts

Crowd Safety Advisor
Carl Kruger

Interested In Learning More?

020 3151 9275

invest@spectrumx.com